Novel Quantitative Method to Evaluate Globotriaosylceramide Inclusions in Renal Peritubular Capillaries by Virtual Microscopy in Patients With Fabry Disease
Authors:
- Laura BarisoniLBLaura Barisoni
- J. Charles JennetteJJJ. Charles Jennette
- Robert ColvinRCRobert Colvin
- Sheela SitaramanSSSheela Sitaraman
- Alexander BragatABAlexander Bragat
- Jeff CastelliJCJeff Castelli
- Dan WalkerDWDan Walker
- Pol BoudesPBPol Boudes
- 1 July 2012
- journal article
- Published by Archives of Pathology and Laboratory Medicine in Archives of Pathology & Laboratory Medicine
- Vol. 136 (7) , 816-824
Abstract
Context .—Assessing the amount of globotriaosylceramide inclusions in renal peritubular capillaries by a semiquantitative approach is a standard and useful measure of therapeutic efficacy in Fabry disease, achievable by light microscopy analysis. Objective .—To describe a novel virtual microscopy quantitative method to measure globotriaosylceramide inclusions (Barisoni Lipid Inclusion Scoring System [BLISS]) in renal biopsies from patients with Fabry disease. Design .—Plastic embedded 1-µm-thick sections from kidney biopsies from 17 patients enrolled in a Fabry disease clinical trial were evaluated using a standard semiquantitative methodology and BLISS to compare sensitivity. We also tested intrareader and interreader variability of BLISS and compared results from conventional light microscopy analysis with a virtual microscopy-based methodology. Peritubular capillaries were first annotated on digital images of whole slides by 1 pathologist and then scored for globotriaosylceramide inclusions by 2 additional pathologists. Results .—We demonstrated that (1) quantitative analysis by BLISS results in detection of small amount of globotriaosylceramide inclusions even when by semiquantitative analysis the score is 0, (2) application of BLISS combined with conventional light microscopy results in low intrareader and interreader variability, and (3) BLISS combined with virtual microscopy results in significant reduction of intrareader and interreader variability compared with BLISS–light microscopy. Conclusions .—BLISS is a simpler and more sensitive scoring system compared to the semiquantitative approach. The virtual microscopy–based methodology increases accuracy and reproducibility; moreover, it provides a permanent record of retrievable data with full transparency in clinical trials.Keywords
This publication has 15 references indexed in Scilit:
- Response of women with Fabry disease to enzyme replacement therapy: Comparison with men, using data from FOS—the Fabry Outcome SurveyMolecular Genetics and Metabolism, 2011
- Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry diseaseKidney International, 2011
- Virtual microscopy—The future of teaching histology in the medical curriculum?Annals of Anatomy - Anatomischer Anzeiger, 2010
- Enzyme Replacement Therapy for Fabry DiseaseDrugs, 2009
- The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibilityKidney International, 2009
- Overview of telepathology, virtual microscopy, and whole slide imaging: prospects for the futureHuman Pathology, 2009
- Virtual microscopy: Applications to hematology education and trainingHematology, 2005
- Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapyKidney International, 2002
- New Prospects for the Treatment of Lysosomal Storage DiseasesDrugs, 2002
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986